Literature DB >> 8549175

Quantitative CT predicts the severity of physiologic dysfunction in patients with lymphangioleiomyomatosis.

R S Crausman1, D A Lynch, R L Mortenson, T E King, C G Irvin, V A Hale, J D Newell.   

Abstract

PURPOSE: To assess quantitative high-resolution CT (quantitative CT) as a diagnostic and prognostic tool in pulmonary lymphangioleiomyomatosis.
METHODS: Spirometry, lung volumes, diffusing capacity, exercise physiology, and expiratory high-resolution CT (HRCT) examinations were performed on a cohort of ten patients with the diagnosis of lymphangioleiomyomatosis (LAM) referred to a tertiary care center. HRCT examinations were also done on ten normal control subjects. A thresholding technique was used to quantitatively assess the amount of abnormal cystic parenchyma present on each of the two images obtained for each subject with LAM and for each normal control subject. This numeric index of cystic parenchyma, the quantitative CT index, was then examined (1) as a diagnostic measure to distinguish the subjects with LAM from the normal control subjects and (2) as a prognostic measure to assess disease severity in the subjects with LAM. Linear regression of the quantitative CT index against physiologic indexes of pulmonary function and exercise performance was analyzed to determine the relationship between this radiologic assessment of disease severity and functional impairment.
RESULTS: The quantitative CT index was significantly greater for the LAM patients, 37.2 +/- 6.9 (SEM), compared with the control group, 0.8 +/- 0.2 (p = 0.0001). Linear regression analysis demonstrated significant linear correlation between the quantitative CT index and measures of airflow (FEV1, r = -0.90, p = 0.0005), air trapping (residual volume, r = 0.70, p = 0.02), diffusing capacity (diffusing capacity for carbon monoxide, r = -0.76, p = 0.01), gas exchange (alveolar to arterial oxygen gradient) at rest, r = 0.69, p = 0.007, and at maximum exercise, r = 0.79, p = 0.007) and exercise performance (maximum workload, r = -0.84, p = 0.002), and oxygen utilization (oxygen utilization at maximum exercise, r = -0.76, p = 0.01).
CONCLUSION: Quantitative CT techniques can distinguish subjects with LAM from normal controls. Further, the quantitative CT index correlates well with physiologic measurements of airflow, lung volumes, diffusing capacity, and exercise performance and, thus, may provide a useful measure of disease severity.

Entities:  

Mesh:

Year:  1996        PMID: 8549175     DOI: 10.1378/chest.109.1.131

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

Review 1.  Lung densitometry: why, how and when.

Authors:  Mario Mascalchi; Gianna Camiciottoli; Stefano Diciotti
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

2.  The natural history of lymphangioleiomyomatosis: markers of severity, rate of progression and prognosis.

Authors:  Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

3.  Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules.

Authors:  Giulia Veronesi; Eva Szabo; Andrea Decensi; Aliana Guerrieri-Gonzaga; Massimo Bellomi; Davide Radice; Stefania Ferretti; Giuseppe Pelosi; Matteo Lazzeroni; Davide Serrano; Scott M Lippman; Lorenzo Spaggiari; Angela Nardi-Pantoli; Sergio Harari; Clara Varricchio; Bernardo Bonanni
Journal:  Cancer Prev Res (Phila)       Date:  2010-12-16

4.  Clinical CT underestimation of the percentage volume occupied by cysts in patients with lymphangioleiomyomatosis.

Authors:  Thomas C Larsen; Amir M Hasani; Shirley F Rollison; Tania R Machado; Amanda M Jones; Patricia Julien-Williams; Marcus Y Chen; Joel Moss; Han Wen
Journal:  Clin Imaging       Date:  2019-11-27       Impact factor: 1.605

5.  Budesonide versus placebo in high-risk population with screen-detected lung nodules: rationale, design and methodology.

Authors:  Matteo Lazzeroni; Aliana Guerrieri-Gonzaga; Davide Serrano; Maria Clara Varricchio; Giulia Veronesi; Davide Radice; Irene Feroce; Angela Nardi-Pantoli; Scott M Lippman; Eva Szabo; Bernardo Bonanni
Journal:  Contemp Clin Trials       Date:  2010-08-16       Impact factor: 2.226

6.  Lymphangioleiomyomatosis (LAM): molecular insights lead to targeted therapies.

Authors:  Connie G Glasgow; Wendy K Steagall; Angelo Taveira-Dasilva; Gustavo Pacheco-Rodriguez; Xiong Cai; Souheil El-Chemaly; Marsha Moses; Thomas Darling; Joel Moss
Journal:  Respir Med       Date:  2010-07       Impact factor: 3.415

Review 7.  Thoracoabdominal imaging of tuberous sclerosis.

Authors:  Cara E Morin; Nicholas P Morin; David N Franz; Darcy A Krueger; Andrew T Trout; Alexander J Towbin
Journal:  Pediatr Radiol       Date:  2018-08-04

Review 8.  Challenges in pulmonary fibrosis. 3: Cystic lung disease.

Authors:  Gregory P Cosgrove; Stephen K Frankel; Kevin K Brown
Journal:  Thorax       Date:  2007-09       Impact factor: 9.139

9.  Evaluation of the extent of pulmonary cysts and their association with functional variables and serum markers in lymphangioleiomyomatosis (LAM).

Authors:  Bruno Guedes Baldi; Mariana Sponholz Araujo; Carolina Salim Gonçalves Freitas; Gustavo Borges da Silva Teles; Ronaldo Adib Kairalla; Olívia Meira Dias; Daniel Antunes Silva Pereira; Suzana Pinheiro Pimenta; Carlos Roberto Ribeiro Carvalho
Journal:  Lung       Date:  2014-09-09       Impact factor: 2.584

10.  Air Travel-Related Spontaneous Pneumothorax in Diffuse Cystic Lung Diseases.

Authors:  Nikolai Wajda; Nishant Gupta
Journal:  Curr Pulmonol Rep       Date:  2018-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.